{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"24"}],"units":"Participants"}],"title":"PTCH1 alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"24"}],"units":"Participants"}],"title":"SUFU alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"17"}],"units":"Participants"}],"title":"KMT2D alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"17"}],"units":"Participants"}],"title":"SMO alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"17"}],"units":"Participants"}],"title":"BCOR alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"24"}],"units":"Participants"}],"title":"PTEN alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"17"}],"units":"Participants"}],"title":"BRCA2 alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"23"}],"units":"Participants"}],"title":"GLI2 alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"17"}],"units":"Participants"}],"title":"SMARCA4 alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"24"}],"units":"Participants"}],"title":"TP53 alteration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"24"}],"units":"Participants"}],"title":"MYCN alteration"}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"26"}],"units":"Participants"}],"description":"Gene alterations, which include single nucleotide variants (SNPs), amplifications, deletions, translocations, indels, and germline alterations are shown for specific genes of interest in the results table.","groups":[{"description":"Medulloblastoma patients \\<3 years of age; histological diagnosis of desmoplastic nodular (DN)/medulloblastoma with extensive nodularity (MBEN); no evidence of metastatic disease (M0); and a surgical gross total resection (GTR) or near total resection (NTR) defined as residual tumor or imaging abnormality (not definite for residual tumor) with a size of less than 1 cm\\^2 on post-op computed tomography (CT) or magnetic resonance imaging (MRI) \\[R0\\])","id":"OG000","title":"Low-Risk Group"},{"description":"Medulloblastoma patients \\<3 years of age, M0, and either R0 resection with any other medullo histology other than DN/MBEN (i.e., classic or large cell anaplastic (LCA)), or with a subtotal resection (with a residual tumor or imaging abnormality with a size of \\>1 cm\\^2 on post-op imaging (R+), and DN/MBEN). Children 3-5 years of age were also included in this group High Risk","id":"OG001","title":"Intermediate-Risk Group"},{"description":"Medulloblastoma patients \\<3 years of age with evidence of metastatic disease","id":"OG002","title":"High-Risk Group"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible medulloblastoma patients (n=81) were included in these analyses. Not all patients had data available for each gene.","reportingStatus":"POSTED","timeFrame":"Based on samples obtained at the time of initial surgery or repeat surgery prior to treatment","title":"Numbers of Patients With Gene Alterations","type":"SECONDARY","unitOfMeasure":"Participants"}